Safe Banking

Current sort has key articles at the top. Click on "Article Date" to sort by date, click on specific "tag" to view all articles in that category.

Title
Mike Crapo wisely puts children before cannabis profits
02/13/2020

In the first nine months of 2019, the marijuana industry spent more than $3.8 million lobbying Congress, according to OpenSecrets — employing a total of 80 lobbyists. That put the industry on track to spend far more on lobbyists in 2019 than in the previous two years combined.

Yet it’s a modest investment considering the potential payout. If enacted, the SAFE Banking Act is expected to drive billions of dollars of new investment into this rapidly evolving sector.


Crapo, Safe Banking
Why Giving Pot Pushers Access to Our Banks Is Dangerous
09/25/2019
It should be called the “Let’s Pretend Marijuana Is Safe and Give Pot Pushers, Cartels, and Terrorist Organizations Access to Our Banking System” Act. 
Don’t hold your breath for a title change. Regardless of the title, the idea behind the act ignores reality and, if passed, will lead to disastrous results.
This bill is all about protecting people and businesses who openly commit federal crimes by selling marijuana, and rewarding them by giving them access to the most important banking system in the world to further give them the patina of legitimacy.
And at the same time the House is considering this bill, the data on the impact of the legalization experiment across the country is proving just what a dangerous and bad idea legalization has become.
The Rocky Mountain High Intensity Drug Trafficking Area report on the impact of legalization in Colorado is devastating for those pushing pot. The report found:

The report also shows that the tax revenue from state-authorized marijuana sales, far from being a game-changer like pot pushers said it would be, amounted to around nine-tenths of 1% (000.9%) of Colorado’s fiscal year 2018 budget. Previous reports are just as bad. 

Pot Is a Schedule I Controlled Dangerous Substance for Good Reason

Passed in 1970, the Controlled Substances Act places marijuana in Schedule I, a category reserved for drugs that are medically unhelpful and dangerous. Schedule I drugs have a high potential for abuse, have no currently accepted medical use in treatment, and a lack of accepted safety for use even under medical supervision.

States have passed so-called medical marijuana laws under the theory that pot has medicinal benefits that can’t be produced by other legal means. In making those claims, pot pushers want us to ignore the fact that today’s marijuana is one of the most genetically modified substances on the earth, has over 500 known carcinogens, has THC levels that dwarf the 1% or 2% levels from the 1970s (levels are now at 20-90% THC), and that there is zero quality, content, or dosage control in their products. 

They are also counting on you not knowing that there are already three FDA-approved THC drugs, and at least five more on the way.   

The dirty little secret they hide from you is that you don’t have to smoke marijuana, eat it in a brownie, or chew it in a marijuana-laced gummy bear to reap the medicinal benefits of THC. A doctor can write you a prescription for those drugs. They can’t write one for marijuana, because it is not a medicine

The three FDA-approved drugs are Marinol, Cesamet, and Syndros. Drugs like Syndros show great promise for countering today’s dangerous “medical marijuana” movement. The companies that sell those FDA-approved drugs do, and should have access to the federal banking system. But those who peddle pot, with sky-high genetically manipulated THC levels that have no medical benefit, shouldn’t.


stimson, blog, Safe Banking, Vaping, HR 1595, SB 1200, medicine
Subscribe to Safe Banking